Skip to main content
Clinical Trials/ITMCTR2100004453
ITMCTR2100004453RecruitingPhase 1

Clinical effect of herbal paste combined with Femoston to treat Premature ovarian insufficiency (POI)

Tongxiang Maternal and Child Health Hospital0 sitesStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Ages
18 to 40 (—)
Sex
Female

Inclusion Criteria

  • 1. Between 18 and 40 years of age;
  • 2. Those who meet the diagnostic criteria of TCM and Western medicine;
  • 3. Urine pregnancy test negative;
  • 4. Those who did not receive any relevant treatment within 3 months prior to the start of the study;
  • 5. Patients with informed consent and voluntary participation, can cooperate with the completion of clinical researchers.

Exclusion Criteria

  • 1. Female reproductive system anatomical abnormalities;
  • 2. In the past three months, the use of hormones, traditional Chinese medicine or acupuncture treatment;
  • 3. Complicated with other gynecological reproductive endocrine diseases, such as endometriosis, hyper prolactinemia, polycystic ovary syndrome, gonadal dysplasia;
  • 4. History of autoimmune diseases;
  • 5. Patients with severe primary diseases, such as cardiovascular and cerebrovascular diseases, liver, kidney and hematopoietic system; Those who participated in other clinical trials at the same time did;
  • 6. Not end or took other drugs that affected the study;
  • 7. There are contraindications of acupuncture, such as large area of skin infection, rupture and so on;??
  • 8. Not according to the prescribed medication, can not judge the efficacy, or incomplete data and other effects on the efficacy of the judge.

Investigators

Sponsor
Tongxiang Maternal and Child Health Hospital

Similar Trials